Cutaneous melanoma in Switzerland - Epidemiology and hints for prevention;Von der Epidemiologie des Melanoms zur Prävention -Fakten und Hinweise

Therapeutische Umschau

Volumn 56, Issue 6, 1999, Pages 292-297

  Schuler G ^a   Hardmeier, Th ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHILD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; CULTURAL FACTOR; FEMALE; HEALTH; HEALTH EDUCATION; HUMAN; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; RADIATION INJURY; SKIN TUMOR; SWITZERLAND; ULTRAVIOLET RADIATION;

ADULT; AGED; CHILD; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH EDUCATION; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; SKIN NEOPLASMS; SWITZERLAND; ULTRAVIOLET RAYS; WORLD HEALTH;

EID: 0033142417     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.56.6.292     Document Type: Article

References (33)

1. Andrey M. Primäre Prävention. In: Burg G, ed. Hautkrebs: das maligne Melanom. Fakten und Handlungsbedarf. Bern: BAG, Schweizerische Krebsliga, 1998: 55-57.
2. Armstrong BK, English DR, Cutaneous malignant melanoma. In: Schottenfeld D, Fraumeni JF. Cancer epidemiology and prevention. New York: Oxford University Press. 1996: 1282-1312.
3. Bergenmar M, Ringborg U, Måhnsson-Brahme E, Brandberg V. Nodular histogenetic type - the most significant factor for thick melanoma: implications for prevention. Melanoma Res 1998; 8: 403-411.
4. Bleyen L, De Bacquer D, Myny K, Brochez L, Naeyaert JM, De Backer G. Trends in mortality from cutaneous malignant melanoma in Belgium. Int J Epidemiol 1999; 28: 40-45.
5. Bouchardy C, Schüler G, Hotz P, Minder C, Raymond L (für die Vereinigung Schweizerischer Krebsregister). Cancer risks by occupation. In Vorbereitung.
6. Burton RC, Coates MS, Hersey P, et al. An analysis of a melanoma epidemic. Int J Cancer 1993; 55: 765-770.
7. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and non cutaneous melanoma. A summary of 84 836 cases from the past decade. Cancer 1998; 83: 1664-1678.
8. CRC Melanoma Pathology Panel: A nationwide survey of observer variation in the diagnosis of thin cutaneous melanoma including the MIN terminology. J Clin Path 1997; 50: 202-205.
9. Franceschi S, La Vecchia C, Negri E, Levi F. Increases in mortality from cutaneous melanoma in southern Europe. Int J Cancer 1992; 51: 160-162.
10. Frisch M, Hjalgrim H, Olsen JH, Melbye M. Risk for subsequent cancer after diagnosis of basal-cell carcinoma. Ann Intern Med 1996; 125: 815-821.
11. Gloeckler Ries LA, Kosary CL, Hankey BF, Miller BA, Harras A, Edwards BK. SEER cancer statistics review. 1973-1994. Bethesda: (NIH No. 97-2789), 1997.
12. HEPINFO [Steffen R]. Hepatitis-B-Risiko: Reisende Schweizer sind leider Spitzenreiter. Ars Medici Dossier 1998; VI: 32-33.
13. Koh HK, Geller AC. Public health interventions for melanoma. Hemat Oncol Clin North Am 1998; 12 (4): 903-928.
14. La Vecchia C, Lucchini F, Negri E, Levi F. Recent declines in worldwide mortality from cutaneous melanoma in youth and middle age. Int J Cancer 1999; 81: 62-66.
15. Levi F, Franceschi S, Te VC, Randimbison L, LaVecchia C. Trends of skin cancer in the Canton of Vaud, 1976-92. Br J Cancer 1995; 72: 1047-1053.
16. Levi F, Randimbison L, LaVecchia C, Erler G, Te VC. Incidence of invasive cancers following squamous cell skin cancer. Am J Epid 1997; 146: 734-739.
17. Levi F, LaVecchia C, Te VC, Randimbison L, Erler G. Incidence of invasive cancers following basal cell skin cancer. Am J Epid 1998; 147: 722-726.
18. MacKie RM, Hole DJ. Incidence and thickness of primary tumours and survival of patients with cutaneous malignant melanoma in relation to socioeconomic status. Brit J Med 1996; 312: 1125-1128.
19. MacKie RM, Hunter JAA, Aitchison TC, et al. Cutaneous malignant melanoma, Scotland 1979-89. Lancet 1992; 339: 971-975.
20. Melia J. Changing incidence and mortality from cutaneous malignant melanoma. Brit med J 1997; 315: 1106-1107.
21. Mooi WJ. Diagnosis of thin melanoma. J Clin Path 1997; 50: 179-180.
22. Parkin DM et al. ed. Cancer Incidence in Five Continents: Vol VI. IARC Sci Publ 1992, 120; Vol. VII. IARC Sci Publ 1997, 143.
23. Parkin DM et al. ed. Cancer Incidence in Five Continents: Vol VI. IARC Sci Publ 1992, 120; Vol. VII. IARC Sci Publ 1997, 143.
24. Rees JL. The melanoma epidemic: reality and artefact. Warrants a reappraisal of the relation between histology and clinical behaviour. Brit med J 1996; 312: 137-138.
25. Rünger TM. Pregnancy, nevi and melanoma. In: Altmeyer P, Hoffmann K, Stücker M, eds. Skin Cancer and UV Radiation. Berlin, Heidelberg: Springer, 1997: 572-576.
26. Schüler G, Levi F, Raymond L, Pury P. Die Schweiz, ein Land mit hohen Melanomraten. In: Burg G, ed. Hautkrebs: das maligne Melanom. Fakten und Handlungsbedarf. Bern: BAG, Schweizerische Krebsliga, 1998: 5-10.
27. Schüler G, Bopp M. Atlas der Krebsmortalität in der Schweiz 1970-1990. Basel: Birkhäuser, 1997: Band C, 129-135.
28. Scotto J, Pitcher H, Lee JAH. Indications of future decreasing trends in skin-melanoma mortality among whites in the Unites States. Int J Cancer 1991; 49: 490-497.
29. Van der Esch EP, Muir CS, Nectoux J, et al. Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int J Cancer 1991; 47: 483-490.
30. Wassberg C, Thörn M, Yuen J, Ringborg U, Hakulinen T. Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden. Brit J Cancer 1996; 73: 255-259.
31. Wassberg C, Thörn M, Yuen J, Ringborg U, Hakulinen T. Second primary cancers in patients with squamous cell carcinoma of the skin: a population-based study in Sweden. Int J Cancer 1999; 80: 511-515.
32. Weinstock MA. Issues in the epidemiology of melanoma. Hemat Oncol Clin North Am 1998; 12 (4): 681-688.
33. Wüthrich A. Histopathologie und Inzidenz des malignen Melanoms der Haut im Kanton Zürich 1985-1988; 39. Inaugural-Dissertation Zürich 1994.